| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gabriel Ling is Director at TOI. Gabriel Ling's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Gabriel Ling has 5 Form 4 filings on record from November 2022 to November 2025, all as Director at Oncology Institute (TOI), 2022–2025.
The 6 reported transactions were 5 stock awards and 1 other transaction.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria